(Q33394689)
Statements
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms (English)
John D Roberts
William D Figg
Beata Holkova
E Brent Perkins
Viswanathan Ramakrishnan
Mary Beth Tombes
Ellen Shrader
Neha Talreja
Martha D Wellons
G David Roodman
Domenico Coppola
Loveleen Kang
Jana Dawson
Cody Peer
Sarah Kolla
Austin Doyle
John Wright
Daniel M Sullivan
1 reference